Coronavirus Drug Discovery
eBook - ePub

Coronavirus Drug Discovery

Volume 3: Druggable Targets and In Silico Update

  1. 406 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Coronavirus Drug Discovery

Volume 3: Druggable Targets and In Silico Update

About this book

Coronavirus Drug Discovery, Volume Three: Druggable Targets and In Silico Update presents comprehensive information on drug discovery against COVID-19. Chapters in Part One of this volume describe the various druggable targets and associated signaling pathways for effective targeting of SARS-CoV-2. In Part Two, chapters discuss the various computational approaches and in silico studies against SARS-CoV-2. Written by global team of experts, this book is an excellent resource that will be extremely useful to drug developers, medicinal chemists, pharmaceutical companies in R&D, research institutes in both academia and industry, and the National Library of Medicines and Health. In addition, agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, World Health Organization, European Medicines Agency, the US Food and Drug Administration, and all others involved in drug discovery against COVID-19 will find this book useful. - Discusses the pathogenic mechanisms of SARS-CoV-2 and druggable targets - Reviews the various signaling pathways associated with SAR-CoV-2 as possible druggable targets - Presents computational approaches and in silico studies against SARS-CoV-2

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Coronavirus Drug Discovery by Chukwuebuka Egbuna in PDF and/or ePUB format, as well as other popular books in Medicina & Industria farmaceutica, biotecnologica e sanitaria. We have over one million books available in our catalogue for you to explore.

Table of contents

  1. Coronavirus Drug Discovery
  2. Cover
  3. Title Page
  4. Copyright Page
  5. Table of Contents
  6. List of Contributors
  7. Chapter 1 SARS-CoV-2 genome sequencing and promising druggable targets
  8. Chapter 2 Signaling pathways implicated in SARS-CoV-2 infection
  9. Chapter 3 Roles of membrane lipids and lipid synthesis inhibitors in the propagation of coronavirus disease
  10. Chapter 4 Potential drugs in SARS-CoV-2 treatment
  11. Chapter 5 Natural drugs for the treatment of severe acute respiratory syndrome coronaviruses infections (SARS-CoV and COVID-19): a complete review of in vitro, in vivo, in silico, and clinical studies
  12. Chapter 6 Plants with potent antiviral properties
  13. Chapter 7 Herbal-based resources against exanthematous viral infections and other viral diseases
  14. Chapter 8 Dietary polyphenols as therapeutic agents to combat COVID-19
  15. Chapter 9 Computational demonstration of cheminformatics and machine learning in coronavirus drug discovery
  16. Chapter 10 In silico approaches in drug discovery for SARS-CoV-2
  17. Chapter 11 Application of molecular docking and dynamics tools in SARS-CoV-2 drug design
  18. Chapter 12 Molecular dynamic simulation with protein and detection of repurposable drugs for COVID-19
  19. Chapter 13 Computation-guided inhibitor screening against the nucelocapsid of SARS-CoV-2
  20. Chapter 14 In silico insight into the interaction of 4-aminoquinolines with selected SARS-CoV-2 structural and nonstructural proteins
  21. Chapter 15 In silico evaluation of anti-SARS-CoV-2 activity of Punica granatum L. phytochemicals
  22. Chapter 16 In silico investigation and identification of bioactive compounds from medicinal plants as potential inhibitors against SARS-CoV-2 cellular entry
  23. Index